Michael Kchlinsky

Company: Carisma Therapeutics

Job title: Co-Founder

Seminars:

Development of CT-0508, a First-in-Class CAR-M, for Solid Tumour Immunotherapy 2:30 pm

Key rationale for development of monocyte/macrophage based therapeutics Overview of Carisma’s proprietary engineered mono/macrophage cell therapy technology CT-0508: clinical trial in progress updateRead more

day: Focus Day - Track B - Evening